Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis

Experimental Eye Research(2022)10.1016/j.exer.2022.109344Source: DataRank Database

Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis is a research paper published in Experimental Eye Research (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.94)OA: hybridTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Rebecca E.H. Whiting ORCID,Juri Ota‐Kuroki ORCID,Leilani J. Castaner,Brandie Morgan-Jack,Julianna C. Sabol

Live enrichment

PubMed:36509165 PMC:PMC9839638 OpenAlex:https://openalex.org/W4311767157

National Institutes of Health

Grant: EY030081

National Institutes of Health

Grant: EY031674

NEI NIH HHS

Grant: R01 EY030081

NEI NIH HHS

Grant: R01 EY031674

NEI NIH HHS

Grant: R01 EY018815

National Institutes of Health

Grant: 1R01EY031674-01A1

Gene therapy for preserving the visual system in lysosomal storage diseases

National Institutes of Health

Grant: 5R01EY030081-02

Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.exer.2022.109344

publisherhttps://doi.org/10.1016/j.exer.2022.109344

publisherhttps://api.elsevier.com/content/article/PII:S0014483522004250?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0014483522004250?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36509165

Fields of Study

Retinal Development and DisordersLysosomal Storage Disorders ResearchRetinal Diseases and Treatments0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsChildDogsHumansDisease Models, AnimalGenetic TherapyNeuronal Ceroid-LipofuscinosesRetinaRetinal DegenerationTripeptidyl-Peptidase 1Intravitreal Injections

MeSH Terms

Tripeptidyl-Peptidase 1AnimalsChildDisease Models, AnimalDogsHumansNeuronal Ceroid-LipofuscinosesRetinaRetinal DegenerationGenetic TherapyIntravitreal Injections

Keywords

RetinalElectroretinographyRetinaRetinal degenerationBatten diseaseNeuronal ceroid lipofuscinosisLateral geniculate nucleusOptic nerveBiologyOphthalmologyPathologyMedicineNeuroscienceDiseaseElectroretinogramLysosomal Storage DiseaseOcular Gene TherapyTripeptidyl PeptidaseTripeptidyl-Peptidase 1Genetic TherapyDisease Models, AnimalDogsNeuronal Ceroid-LipofuscinosesIntravitreal InjectionsAnimalsHumansChild

Sustainable Development Goals

SDG 0: Good health and well-being